CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, has received a Good Manufacturing Practice (GMP) ...
Aurobindo Pharma subsidiary CuraTeQ Biologics has received a GMP certificate of compliance for its biosimilars manufacturing ...
"Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received a certificate of Good Manufacturing Practice (GMP) compliance from the Medicines and Healthcare products ...
The company has has end-to-end capabilities in producing a full range of products from bulk drug substance to fill-finish and ...
CuraTeQ Biologics' EMA GMP certification marks a key milestone in Aurobindo Pharma's expansion into biosimilars, with three ...
Aurobindo Pharma's Hyderabad-based biosimilars facility receives GMP certification from the European Medicines Agency, paving ...
However, the required upgrades present significant technical and financial challenges for smaller manufacturers. Jatish Sheth ...
TipRanks on MSN3d
Athira Pharma’s Regulatory Compliance Challenges Threaten Drug Development PipelineAthira Pharma, Inc. (ATHA) has disclosed a new risk, in the Regulation category. Athira Pharma, Inc. faces significant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback